Changes in Profiles of Kawasaki Disease Noted over Time in Suzhou, China

Objectives: The purpose of the present study was to explore the changes in epidemiological, clinical and laboratory characteristics of Kawasaki disease (KD) over a 12-year period in this area. Methods: The medical records of KD patients hospitalized in the Children’s Hospital of Soochow University from January 2006 to December 2017 were retrospectively reviewed and analyzed. To elucidate the changes more clearly in these years, we divided all patients into three groups according to the time of admission, 5-year time intervals apart. Results: We found the number of KD had increased in recent years, although the age compositions had some variances. The male-to-female ratio peaked in patients aged 6–11 months and then decreased with ages. Incidence rates of clinical characteristics were almost the same except for cervical lymphadenopathy. Significant differences were noted in percentage of neutrophils, albumin, C-reactive protein, erythrocyte sedimentation rate (ESR) and platelets. However, only ESR and platelets were significantly different after adjusting the days of disease onset. A trend showing a shorter fever duration before intravenous immunoglobulin treatment was also noted. Conclusions: The number of KD was increasing annually. Our results were indicative of a possibly changed etiology of the disease. However, further large-scale long-term surveillance is warranted.

[1]  Guo-ying Huang,et al.  Epidemiologic Features of Kawasaki Disease in Shanghai From 2013 Through 2017 , 2019, Journal of epidemiology.

[2]  K. Kotani,et al.  Epidemiological observations of Kawasaki disease in Japan, 2013–2014 , 2018, Pediatrics international : official journal of the Japan Pediatric Society.

[3]  Hiroyuki Suzuki,et al.  Patient Age and the Seasonal Pattern of Onset of Kawasaki's Disease. , 2018, The New England journal of medicine.

[4]  T. Fukaya,et al.  Kawasaki disease: Epidemiological differences between past and recent periods, and implications of distribution dynamism , 2018, Pediatrics international : official journal of the Japan Pediatric Society.

[5]  L. Schonberger,et al.  Cardiac Complications, Earlier Treatment, and Initial Disease Severity in Kawasaki Disease , 2017, The Journal of pediatrics.

[6]  H. Kil,et al.  Changes in clinical and laboratory features of Kawasaki disease noted over time in Daejeon, Korea , 2017, Pediatric Rheumatology.

[7]  Sohee Park,et al.  Epidemiology and Clinical Features of Kawasaki Disease in South Korea, 2012–2014 , 2017, The Pediatric infectious disease journal.

[8]  M. Krucoff,et al.  Coronary Artery Complication in Kawasaki Disease and the Importance of Early Intervention : A Systematic Review and Meta-analysis. , 2016, JAMA pediatrics.

[9]  Yunjia Tang,et al.  Epidemiological and Clinical Characteristics of Kawasaki Disease and Factors Associated with Coronary Artery Abnormalities in East China: Nine Years Experience. , 2016, Journal of tropical pediatrics.

[10]  Fang Liu,et al.  Epidemiologic Features of Kawasaki Disease in Shanghai From 2008 Through 2012 , 2015, The Pediatric infectious disease journal.

[11]  Ping Huang,et al.  Influenza infection and Kawasaki disease. , 2015, Revista da Sociedade Brasileira de Medicina Tropical.

[12]  K. Kotani,et al.  Descriptive epidemiology of Kawasaki disease in Japan, 2011-2012: from the results of the 22nd nationwide survey. , 2015, Journal of epidemiology.

[13]  K. Kotani,et al.  Cardiac lesions and initial laboratory data in Kawasaki disease: a nationwide survey in Japan. , 2015, Journal of epidemiology.

[14]  T. Kuijpers,et al.  Five Years of Kawasaki Disease in the Netherlands: A National Surveillance Study , 2014, The Pediatric infectious disease journal.

[15]  K. Maslin,et al.  The Epidemiology and Clinical Features of Kawasaki Disease in Australia , 2014, Pediatrics.

[16]  Jung-Woo Rhim,et al.  Changes in Kawasaki Disease During 2 Decades at a Single Institution in Daejeon, Korea , 2014, The Pediatric infectious disease journal.

[17]  Chin‐Yun Lee,et al.  Estimation of the incidence of Kawasaki disease in Taiwan. A comparison of two data sources: nationwide hospital survey and national health insurance claims. , 2014, Pediatrics and neonatology.

[18]  Xiaodong Zhao,et al.  Clinical Characteristics of Kawasaki Syndrome and the Risk Factors for Coronary Artery Lesions in China , 2013, The Pediatric infectious disease journal.

[19]  R. Holman,et al.  Kawasaki Syndrome and Factors Associated With Coronary Artery Abnormalities in California , 2012, The Pediatric infectious disease journal.

[20]  Jinghui Sun,et al.  Epidemiologic Survey of Kawasaki Disease in Jilin from 1999 Through 2008 , 2011, Pediatric Cardiology.

[21]  Junbao Du,et al.  VALGANCICLOVIR FOR CONGENITAL CMV INFECTION: A PILOT STUDY ON PLASMA CONCENTRATION IN NEWBORNS AND INFANTS , 2007, The Pediatric infectious disease journal.

[22]  J. Furui,et al.  Risk factors associated with the need for additional intravenous gamma-globulin therapy for Kawasaki disease. , 2006, Acta paediatrica.

[23]  J. Furui,et al.  Risk factors associated with the need for additional intravenous gamma‐globulin therapy for Kawasaki disease , 2006, Acta paediatrica.